Table 4.

Agreement in the detection of high-risk HPV types between HC2 and PCR assay among 912 women, Vanuatu 2009–2010

HC2-negativeHC2-positiveaTotal
HPV testn (%)n (%)n (%)
PCR-negative642b685 (75.1)1834 (3.7)719 (78.8)
PCR low-risk only4316
PCR high-risk79c (8.7)114 (12.5)193 (21.2)
Total764 (83.8)148 (16.2)912 (100)

NOTE: κ test = 0.59.

  • aThe sensitivity and specificity of HC2 versus PCR assay were, respectively, 59.1% (95% CI, 51.8%–66.1%) and 95.3% (95% CI, 93.5%–96.7%).

  • bIncluding 5 HSILs.

  • cIncluding 2 invasive cervical carcinomas with inadequate cytology but positive for HPV16 and HPV52/30 at PCR.